MedPath

GEN-PROBE INCORPORATED

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

Completed
Conditions
HIV-1 Infection
First Posted Date
2014-01-03
Last Posted Date
2017-02-23
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
468
Registration Number
NCT02026752
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

🇺🇸

Community AIDS Network, Sarasota, Florida, United States

🇺🇸

University of Miami - AIDS Clinical Research Unit, Miami, Florida, United States

and more 6 locations

Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System

Completed
Conditions
Neisseria Gonorrhoeae Infection
Chlamydia Trachomatis
Interventions
Device: APTIMA COMBO 2 Assay (AC2 Assay)
First Posted Date
2012-11-26
Last Posted Date
2014-01-14
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
1912
Registration Number
NCT01733069
Locations
🇺🇸

Planned Parenthood Northeast Ohio, Akron, Ohio, United States

🇺🇸

Planned Parenthood Houston and Southeast Texas, Houston, Texas, United States

🇺🇸

New England Center for Clinical Research, Fall River, Massachusetts, United States

and more 4 locations

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

Terminated
Conditions
Chlamydia Infections
Gonorrhea
Trichomonas Infections
Interventions
Device: APTIMA® Trichomonas vaginalis & APTIMA® COMBO 2® Assays
First Posted Date
2012-11-16
Last Posted Date
2017-08-16
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
1336
Registration Number
NCT01728103
Locations
🇺🇸

John Hopkins University, Baltimore, Maryland, United States

🇺🇸

Planned Parenthood Southeastern Pennsylvania, Philadelphia, Pennsylvania, United States

🇺🇸

Cincinnati Children's Hospital Medical Center Division of Pediatric & Adolescent Gynecology, Cincinnati, Ohio, United States

and more 11 locations

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS

Completed
Conditions
Dengue
Interventions
Device: Procleix Dengue Virus Assay
First Posted Date
2012-10-08
Last Posted Date
2014-09-15
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
150000
Registration Number
NCT01702272
Locations
🇺🇸

Creative Testing Solutions - Tampa, St Petersburg, Florida, United States

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Completed
Conditions
Human Papillomavirus Infection
Interventions
Device: APTIMA HPV Assay
First Posted Date
2012-09-27
Last Posted Date
2012-11-14
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
2200
Registration Number
NCT01694875
Locations
🇺🇸

Hennepin County Medical Center, Minneapolis, Minnesota, United States

🇺🇸

Laboratory Corporation of America, Burlington, North Carolina, United States

🇺🇸

Molecular Pathology Laboratory Network, Inc, Maryville, Tennessee, United States

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red Cross

Completed
Conditions
Dengue
Interventions
Device: Procleix Dengue Virus Assay
First Posted Date
2012-08-02
Last Posted Date
2015-03-20
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
35035
Registration Number
NCT01656174
Locations
🇺🇸

Creative Testing Solutions, Tempe, Arizona, United States

🇺🇸

American Red Cross National Testing Laboratory, Charlotte, North Carolina, United States

Prospective Collection of Female and Male Specimens for PANTHER® System Testing

Completed
Conditions
Chlamydia Infections
Gonorrhea
Interventions
Device: APTIMA Assays; PANTHER System
First Posted Date
2012-07-12
Last Posted Date
2013-10-17
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
1492
Registration Number
NCT01638637
Locations
🇺🇸

AGA Clinical Trials, Hialeah, Florida, United States

🇺🇸

John Hopkins University, Baltimore, Maryland, United States

🇺🇸

Laboratory Corporation of America, Burlington, North Carolina, United States

and more 13 locations

Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System

Completed
Conditions
Human Papilloma Virus Infection
First Posted Date
2011-10-05
Last Posted Date
2012-07-03
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
11816
Registration Number
NCT01446198
Locations
🇺🇸

Hennepin County Medical Center, Minneapolis, Minnesota, United States

🇺🇸

LabCorp Corporation of America, Burlington, North Carolina, United States

🇺🇸

Gen-Probe Incorporated, San Diego, California, United States

Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing

Completed
Conditions
Trichomonas Vaginalis
First Posted Date
2011-09-01
Last Posted Date
2014-02-06
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
532
Registration Number
NCT01427023
Locations
🇺🇸

University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

🇺🇸

Planned Parenthood Gulf Coast, Houston, Texas, United States

🇺🇸

University of Alabama, Birmingham, Birmingham, Alabama, United States

and more 4 locations

APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results

Completed
Conditions
Human Papillomavirus Infection
First Posted Date
2011-06-29
Last Posted Date
2011-10-06
Lead Sponsor
Gen-Probe, Incorporated
Target Recruit Count
1260
Registration Number
NCT01384370
Locations
🇺🇸

North Shore LIJ Health System Laboratories, Lake Success, New York, United States

🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

🇺🇸

Laboratory Corporation of America, Burlington, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath